Tissue Regenix Group plc

Company Profile

Company website
Pharmaceuticals & Biotechnology (Biotechnology)
Tissue Regenix Group plc (AIM: TRX) is a pioneering, international medical technology company focused on the development of regenerative products using two platform technologies, dCELL®, addressing soft tissue needs, and BioRinse™, providing inductive bone allografts.

Investor Access

07 Sep
Event information

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Wednesday  7th September 2022 at 4.30pm relating to its interim results.  Investors can sign up to Investor Meet Company for free, by clicking here

7th September 2022 at 4:30PM
Financial Calendar
 Event Date
Year End31 December
Half  Year End30 June
Preliminary Results*June
Interim Results*7 September

* Months based on previous announcements of this kind